Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Biotech
Sionna goes public in $135M IPO, Aardvark plots $103M listing
Sionna is joining the Nasdaq with an upsized offering, while obesity biotech Aardvark unveiled plans for a nine-figure IPO of its own.
James Waldron
Feb 7, 2025 4:40am
Sionna eyes up $156M IPO to fund cystic fibrosis trials
Feb 3, 2025 9:59am
What to expect from the biotech IPO market in 2025
Jan 31, 2025 9:15am
Metsera, Maze go public with IPOs of $275M, $113M
Jan 31, 2025 7:40am
Judge rules against investor trying to block Aurion IPO
Jan 28, 2025 2:54pm
Cell therapy biotech Aurion joins IPO surge
Jan 27, 2025 2:42pm